论文部分内容阅读
Background Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease that can be classified by immunohistochemistry into 2 subgroups germinal center B-cell-like (GCB) or non-GCB (a subgroup including the activated B-cell-like subtype as well as some intermediate molecular subtypes).